玩股撇步(動畫小學堂)  

  • 營業利益和稅後淨利成長率大於營收成長率, 通常代表公司在成長, 如果是漲很多的股票, 發現沒有這個現象就要留意了
  • 營收到某個數字後, 營業利益產生不成比例的增加, 有可能是規模經濟的效應
  • 如果是有淡旺季的公司, 是否有淡季不淡, 旺季更旺的情況
  • 漲很多的股票要留意 EPS 較上季是否有大幅衰退的情況
  • 如果EPS衰退,要觀察同業是不是有一樣的狀況
  • 要留意增資減資和公司債對股本及EPS的影響
成長能力-近20季
加權平均股數 QoQ YoYEPS QoQ YoY本業EPS QoQ YoY累計EPS QoQ YoY營收 QoQ YoY毛利率(%) QoQ YoY營業利益 QoQ YoY稅後淨利 QoQ YoY稅前淨利率(%) QoQ YoY稅後淨利率(%) QoQ YoY兩季平均(YOY)營收成長率(%)兩季平均(YOY)EPS成長率(%)兩季平均(YOY)本業EPS成長率(%)
23Q4 (20)860.00.00.35288.89131.250.44109.52100.00.9060.71-57.755.2911.3713.0349.63-5.65-11.630.5732.56111.110.3275.0131.259.3837.54150.085.60247.83127.186.21116.9439.76
23Q3 (19)860.00.00.09-55.0-90.110.21-30.0-72.730.5619.15-82.774.751.06-28.2552.601.150.730.43-4.44-60.550.08-52.94-89.746.82-12.34-62.911.61-56.13-86.347.99-39.04113.94
23Q2 (18)860.00.00.20-23.08-89.360.30257.89-83.610.4780.77-79.914.714.91-42.3352.00-2.55-10.870.45275.0-80.430.17-26.09-89.447.78-36.64-72.843.67-33.87-81.451.1550.0635.76
23Q1 (17)860.00.00.26123.21-43.48-0.19-186.36-179.170.26-87.79-43.484.09-12.61-10.1153.36-4.993.170.12-55.56-74.470.23123.96-42.512.28165.56-15.315.55126.94-36.21-20.96-49.94-128.90
22Q4 (16)860.08.86-1.12-223.08-1766.670.22-71.43257.142.13-34.4661.364.68-29.310.6556.167.5532.450.27-75.2358.82-0.96-223.08-1820.0-18.73-201.85-467.25-20.60-274.72-1807.41-24.04-137.34-64.68
22Q3 (15)860.011.690.91-51.618.180.77-57.9232.763.2538.89128.876.62-18.7725.1452.22-10.493.961.09-52.6162.690.78-51.5530.018.39-35.8126.4811.79-40.394.2430.18128.55302.29
22Q2 (14)860.011.691.88308.793.811.83662.5134.622.34408.7260.08.1579.1252.9158.3412.811.552.3389.36177.111.61302.5117.5728.6597.5970.6419.78127.3641.8938.48587.68466.97
22Q1 (13)868.8611.690.46866.67243.750.24271.43209.090.46-65.15243.754.55-2.1521.6651.7221.9813.550.47176.474800.00.4900.0260.014.50184.31817.828.70905.56231.22-7.12379.4473.65
21Q4 (12)792.62.6-0.06-107.79-112.24-0.14-124.14-131.111.32-7.04266.674.65-12.1-9.3642.40-15.59-21.160.17-74.63-67.92-0.05-108.33-113.165.10-64.92-49.55-1.08-109.55-114.71-6.42-64.20-74.89
21Q3 (11)770.00.00.77-20.622025.00.58-25.64480.01.42118.461192.315.29-0.7537.0550.23-3.96-1.80.67-19.28168.00.6-18.922100.014.54-13.4325.1511.31-18.871608.020.88191.25214.46
21Q2 (10)770.01.320.97403.121070.00.78454.551400.00.65303.12822.225.3342.5162.0152.3014.821.470.838400.0654.550.74396.01025.016.79931.19590.9513.94310.26703.467.70118.91152.83
21Q1 (9)770.00.0-0.32-165.31-3300.0-0.22-148.890-0.32-188.89-3300.03.74-27.19.6845.55-15.3-9.35-0.01-101.89-106.67-0.25-165.79-2600.0-2.02-119.98-142.08-6.63-190.33-3257.142.90579.85100.56
20Q4 (8)770.00.00.491325.0-33.780.45350.0-32.840.36376.92-82.865.1332.910.0953.785.14-0.760.53112.0-23.190.381366.67-33.3310.11195.61-30.857.341078.67-39.9325.11692.50308.34
20Q3 (7)771.320.0-0.0460.0-116.670.10266.67-58.33-0.13-44.44-109.563.8617.3310.2951.15-0.76-3.60.25127.27-34.21-0.0362.5-116.673.4240.74-66.21-0.7567.53-114.346.90-520.00133.34
20Q2 (6)76-1.3-1.3-0.10-1100.0-116.39-0.060-111.76-0.09-1000.0-108.043.29-3.52-17.9651.542.57-9.630.11-26.67-83.08-0.08-900.0-117.392.43-49.38-85.41-2.31-1200.0-119.97-15.17-599.33-50.00
20Q1 (5)770.00.00.01-98.65-98.080.00-100.0-100.00.01-99.52-98.083.41-26.82-4.4850.25-7.27-9.150.15-78.26-70.590.01-98.25-97.54.80-67.17-69.370.21-98.28-98.11--0.00
19Q4 (4)770.00.00.74208.330.00.67179.170.02.1054.410.04.6633.140.054.192.130.00.6981.580.00.57216.670.014.6244.470.012.22133.650.0--0.00
19Q3 (3)770.00.00.24-60.660.00.24-52.940.01.3621.430.03.5-12.720.053.06-6.960.00.38-41.540.00.18-60.870.010.12-39.260.05.23-54.80.0--0.00
19Q2 (2)770.00.00.6117.310.00.5121.430.01.12115.380.04.0112.320.057.033.110.00.6527.450.00.4615.00.016.666.320.011.574.140.0--0.00
19Q1 (1)770.00.00.520.00.00.420.00.00.520.00.03.570.00.055.310.00.00.510.00.00.40.00.015.670.00.011.110.00.0--0.00
年/月營收月增率(%)去年同期年增率(%)累計營收累計營收年增率(%)近三月累計營收存貨銷售比備註(年增率變動50%需說明原因)
2024/22.2852.7715.083.7730.935.15N/A-
2024/11.498.5165.81.4965.85.37N/A主要係去年1月春節假期9天,實際工作天少;另逢1月流感季節,客戶對本公司產品需求大增,致合併營收較去年同期增加。
2023/121.38-44.975.4418.82-21.545.291.02-
2023/112.577.0910.7917.44-23.095.071.06-
2023/101.4122.0326.3914.94-26.845.011.07-
2023/91.16-52.6-26.2313.53-29.914.751.24-
2023/82.44112.36-29.3612.38-30.244.851.22-
2023/71.15-8.64-27.869.94-30.454.661.26-
2023/61.26-44.18-48.178.79-30.784.71.21-
2023/52.2589.42-41.997.53-26.674.651.22-
2023/41.19-1.18-35.225.27-17.344.371.3-
2023/31.2-39.23-14.134.09-10.124.091.44-
2023/21.98120.11.762.88-8.334.191.41-
2023/10.9-30.98-24.770.9-24.774.461.32-
2022/121.3-42.18-6.5623.9926.164.681.17-
2022/112.26102.027.4422.6828.754.941.11-
2022/101.12-28.77-2.8820.4331.646.140.89-
2022/91.57-54.6111.3319.3134.46.620.81-
2022/83.45116.8858.7717.7436.917.470.71主係檢驗試劑部門和其他部門之產品,市場需求增加,致整體營收增加。
2022/71.59-34.36-6.8114.2932.57.90.68-
2022/62.43-37.5235.1112.6939.918.150.68-
2022/53.88111.5152.7810.2741.097.120.78主係檢驗試劑部門和其他部門之產品,市場需求增加,致整體營收增加。
2022/41.8430.9884.866.3834.815.191.08主係檢驗試劑部門和其他部門之產品,市場需求增加,致整體營收增加。
2022/31.4-27.9826.684.5521.524.551.19-
2022/21.9562.6915.263.1419.354.541.19-
2022/11.2-14.2726.671.226.674.691.16-
2021/121.4-33.52-18.8919.0121.24.651.14-
2021/112.182.6-1.8517.6226.144.661.14-
2021/101.15-18.34-0.115.5231.24.731.12-
2021/91.41-35.279.0414.3734.585.291.08-
2021/82.1827.2931.0712.9638.15.681.01-
2021/71.71-4.8366.0110.7839.616.050.94主係新冠肺炎疫情,檢驗試劑及感控部門之產品,市場需求增加,及新併入之子公司營收,致整體營收增加。
2021/61.8-29.34125.59.0735.545.331.09主係新冠肺炎疫情,檢驗試劑及感控部門之產品,市場需求增加,致整體營收增加。
2021/52.54155.9267.327.2823.394.641.25主係新冠肺炎疫情,檢驗試劑及感控部門之產品,市場需求增加,致整體營收增加。
2021/40.99-10.242.34.738.153.791.53-
2021/31.11-34.4614.173.749.813.741.57-
2021/21.6978.793.22.638.084.351.35-
2021/10.94-45.1118.070.9418.074.811.23-
2020/121.72-19.556.6115.69-0.335.011.12-
2020/112.1485.858.6913.97-1.134.581.22-
2020/101.15-10.877.9811.83-2.724.11.37-
2020/91.29-22.1925.4610.67-3.753.981.1-
2020/81.6661.221.119.38-6.743.491.26-
2020/71.0329.2623.067.72-8.273.351.31-
2020/60.8-47.57-14.876.69-11.733.291.22-
2020/51.5256.47-8.825.9-11.283.461.16-
2020/40.970.17-30.944.38-12.113.581.12-
2020/30.97-40.76-9.423.41-4.73.411.08-
2020/21.64104.5614.172.44-2.684.050.91-
2020/10.8-50.44-25.270.8-25.274.380.84-
2019/121.61-17.9824.3615.7411.814.650.77-
2019/111.9784.638.4914.1310.534.060.88-
2019/101.073.55-30.512.1610.873.740.96-
2019/91.03-37.2929.2511.0917.63.510.98-
2019/81.6496.222.3510.0616.533.411.01-
2019/70.84-10.58-8.088.4219.773.441.0-
2019/60.94-43.85-27.477.5823.914.010.82-
2019/51.6718.5215.856.6537.644.140.8-
2019/41.4131.3884.384.9846.890.0N/A主係認列香港威高寶齡第二期里程金和台灣寶齡醫療及消費通路及珠海寶展電商通路銷售成長所致
2019/31.07-25.3318.343.5736.00.0N/A-
成長能力-近10年
加權平均股數 YoYEPS YoY本業EPS YoY營收 YoY毛利率(%) YoY營業利益 YoY稅前淨利 YoY稅後淨利 YoY
2023 (10)860.00.90-57.550.76-75.1618.82-21.5551.78-5.81.57-62.081.69-49.250.77-57.69
2022 (9)868.862.1260.613.06202.9723.9926.254.9714.574.14150.913.3381.971.8275.0
2021 (8)792.61.32266.671.01102.019.0121.1647.98-7.541.6557.141.83105.621.04271.43
2020 (7)770.00.36-82.860.50-72.9715.69-0.3251.89-5.51.05-53.120.89-60.620.28-82.61
2019 (6)771.322.100.961.8525.015.7411.7154.91-3.722.245.162.26-7.381.611.26
2018 (5)7611.762.0856.391.4837.0414.0916.2557.03-0.422.1346.92.4470.631.5974.73
2017 (4)689.681.33-8.281.082.8612.1215.5457.272.11.4511.541.4310.850.911.11
2016 (3)6210.711.4511.541.0516.6710.49-12.9556.09-8.151.38.331.2911.210.923.29
2015 (2)5616.671.3031.310.90104.5512.0518.8461.071.721.287.51.1654.670.7352.08
2014 (1)4826.320.99115.220.44340.010.1418.3260.0400.64357.140.75226.090.48166.67

財務分析相關資訊

免責聲明

本網站所有資料僅供參考,如使用者依本資料交易發生交易損失需自行負責,本網站對資料內容錯誤﹑更新延誤不負任何責任。